JISCMail Summaries 2008 -2009

December 2009

PLAN has a Liaison Psychiatry referrer’s survey – but we think you need to be part of PLAN to use this.

 

A consultant from Kingston wished to share our experience of MUS in primary care and polyclinics. There was little initial response but nonetheless a useful discussion ensued.  We for example learnt that the Healthcare for London MUS care pathway was not given the go ahead for commissioning because it needed further piloting - due to concerns about the evidence base and also feasibility issues. There is ‘a pilot happening in City and Hackney and there is also a pelvic pain joint clinic at GST. The aim is eventually that some joint work could happen in polyclinics’.

 

The use of computerised CBT for patients with physical illness was discussed. A useful reference cited was ‘Hind D et al. The acceptability of CCBT for the treatment of depression in people with chronic physical disease, Psychology and Health 2009, 1-14’.

 

St Georges use ‘Beating the Blues’ – around £2000 per package – but the experience was that it doesn’t save much on clinician time – a NZ consultant agreed with this, though acknowledged that ‘it does open up a lot of possibilities for people who are hard to engage if there is txt and email support plus video as part of the CBT package’

 

Happy New Year to all and we hope the 2010s is the decade when Liaison Psychiatry truly flourishes!

 

 

November 2009


 

The psychological consequences of facial trauma were discussed. An East London service sees a variety of problems e.g. PTSD and pain – where the pain can serve as a trigger, perpetuating the problem. Others get a BDD type picture. There are a handful of psychologists working with orthognathic patients.

 

Changing Faces (good website), a UK Charity for facial disfigurement, is the best established group but isn't always locally-represented. They have psychologists and counsellors and useful information leaflets. There is substantial and overlapping literature on facial burns. More good advice, from Leeds naturally, for those (like me!) in a hospital without specialist services and looking for local resources rather than literature - speech and language therapists often see these cases and may know who takes referrals.

 

How do we address looking after hospital staff that self harm? A Canadian response suggested the following: that this would be handled on a case to case basis with some sensitivity to the individual and awareness of confidentiality issues. Professional organisations have their own resources – e.g. we have the excellent Mednet in the KSS deanery. Generally staff would be transferred to another hospital than their own if admission is necessary. Criteria for admission and treatment considerations wouldn't differ dramatically. If there are concerns about professional competence (e.g. drug abuse) then this should be addressed with the patient as to whether the licensing body needs to be involved.

 

 

August 2009


 

There were further discussions about ED risk assessments by A&E staff – St Helier and Southampton both use a lengthy assessment (see JISC archive for detail). Where patients score green (low risk), debate about whether they go home or should there be next day liaison follow up clinic? Also in Southampton they have an agreement with A&E that after 2am, patients can stay on CDU to be seen by Liaison Psychiatry the next day.

 

The diagnosis of Korsakoff’s Syndrome in the GH was a subject of debate. Scotland and Southampton don't routinely MRI if the history and clinical presentation are in keeping, but often do CT to rule out subdural. Addenbrookes and OT functional assessments are performed before referring to Social Services in Scotland.

 

In Southampton if it is alcohol dementia then referral is to OPMH and health often fund. But if pure memory impairment (eg Korsakoffs) or not progressive problem then social care will fund care. These patients are a challenge to place. Leicester: 2 fabulous presentations around diagnosis – please see archive.

 

The European Delirium Association is holding its annual meeting in Leeds on 8-9 October. 

 

Concerns in one hospital were raised about a proposed ward policy for dependent drinkers: ‘a policy of sending dependent drinkers home with instructions to drink immediately after any medical problems are excluded’. Many Liaison psychiatrists expressed concerns at this idea.

The College Report on Psychiatry in A&E states:

 

  • Alcohol detoxification requires appropriate supervision.
  • It should not be initiated in those patients discharged from A&E unless such support has been arranged.
  • If resources for immediate detoxification are not available, then motivated patients should be advised to continue drinking and to gradually cut down their intake in order to avoid potentially dangerous withdrawal symptoms.
  • In the meanwhile, appropriate follow-up should be arranged.

 

Further discussion took place about patients on wards that were starting to withdraw and there was a strong body of opinion that detoxes should be completed. However symptom triggered detoxes (Lingford-Hughes AR, Welch S & Nutt DJ (2004) Evidence based guidelines for the pharmacological management of substance misuse, addiction and co-morbidity: recommendations from the British Assocaition of Psychopharmacology. Journal of Psychopharmacology 18(3) 203-335) are successfully used as described below in Ireland:

 

  • Brief as opposed to prolonged medical admissions can usually be identified early on.
  • Admitting such patients to the CDU in our ED allows the patients to have symptom-triggered detox (CIWA =/- Diazepam 20mg every 90 minutes). None of these patients are sent home on benzodiazepines as detox generally takes less than one day.

 

CDU is a more controlled environment than the medical and surgical wards (such wards preclude the use of a symptom-triggered method of detox) and thus the fixed dose tapering standard-regimen of chlordiazepoxide is used in these general wards. This generally shouldn’t take longer than 5 days but such a delay can be problematic wrt completion of detox. Not a reason to tell the person to go home and start drinking again! We need to be convincing colleagues of the futility of such an approach. Reminding them of the likely alcohol-related reason for admission in the first place. Reminding them of Rumpf et al’s Archives paper some years ago on alcohol dependent patients in the general hospital being more ‘ready for action’ by comparison with those in the community.

 

 

July 2009 


 

A lot of discussion took place about risk assessment tools within the general hospital. I liked the Australian view – that good psychosocial clinical assessment trumped any known tool. However, the point was raised about the first contact being A&E staff, where mental health competence is more doubtful – and perhaps a risk assessment tool here would be of value. For ED staff 3 risk tools were cited from Southampton, St Helier and Bristol – they are all excellent and I recommend you look at the JISC archive for details. Southampton have also developed a tool for mental health assessment by Liaison staff.

 

There was a discussion about ways of monitoring and ensuring safety and protection from self harm in inpatient units. A useful tool from the Australian Newcastle (though actual origin unknown) was shared.

 

Rio hasn't hit Worthing, but reading your numerous opinions on its usefulness and usability I frankly hope it never does. And using it takes longer than to see a new patient? Our man in Guys suggests we lobby against it – go Al!

 

Other not very useful electronic activities include a mapping of Liaison Services in the UK which is not very accurate.

 

We thank a breath of fresh clinical air with an unusual case presentation of episodic psychosis always preceded by a mild pyrexia. It seems there may be a neurotransmitter 'something' going on, with an uncle with 'Stiff man syndrome' and the patient having neuroleptic hypersensitivity; but other clinical phenomena are puzzling here. Steroid treatment was a suggestion from across the pond.

 

 

June 2009


 

Nationally, there are high levels of postoperative delirium reported for pseudomyoma surgery – question raised about possible prophylactic medication to prevent this. Some useful references:

 

 

This was from Sydney:

Haloperidol

  • Kalisvaart (2005): DBPCT (N=430, mean age 79, 13.5% became delirious) of haloperidol 1.5mg/d (started one or two days pre op) in hip surgery patients judged to be at high risk for post-operative delirium and continued for up to 3 days postoperatively. Low-dose haloperidol prophylactic treatment did appear to have positive effect on the severity and duration of delirium (5.4 versus 11.8 days) and length of hospital stay (17.1 ± 11.1 versus 22.6 ± 16.7).
  • Kaneko (1999) N=78 RCT (non-blinded) haloperidol 5mg/d IV for 5 days pre gastro surgery & found decreased incidence.
  • Lonergan (2007) reviewed efficacy and adverse effects of haloperidol cf risperidone, olanzapine and quetiapine for treatment of delirium. No evidence that haloperidol in low (<3mg) dose has different efficacy compared to olanzapine or risperidone or that it has more adverse effects.

Olanzapine

  • Larsen: DBRCT (N=400) of perioperative olanzapine (5mg preop & 5mg postop on day of surgery) verses placebo to prevent post-operative delirium in hip & knee replacement surgery over 65yrs. Incidence of delirium of 41% in PBO & 15% in the olanzapine arm (p>0.001).

 

 

Clinical governance in Liaison psychiatry – where do we sit?

In Leeds, this is mainly within the mental health trust, but some policies and procedures sit within the acute trust. Islington similarly straddle both trusts – some aspects are OK e.g. self harm guideline, but this can be tricky where there are differences e.g. rapid tranquilisation policy.

 

Swine flu

Else asked what could be the impact to liaison psychiatry services. From Scotland: 1. staff sickness, 2. FFP3 masks – is there any experience? 3. neuropsychiatric effects of relenza and tamiflu? – reported suicidality in adolescents cited.

 

There were requests for expertise on: 1. setting up an old age liaison service when there is extra funding and 2. Providing psychological support for renal patients – advice given on where to find information and who to visit.

 

 

May 2009


 

A much quieter month for JISCmail.

 

We had an update on our patient with conversion blindness who remains without sight. Midazolam neither helped diagnostically nor therapeutically and the plan was for a specialist neurology ophthalmologist and a hypotherapist psychologist.

 

An interesting American case was presented of a gentleman with lymphoma who was about to receive haemodialysis and who despite not being depressed suffered with complete lack of libido. A helpful response from Guys was to do an endocrine screen – in particular to look for low testosterone and high FSH; and that dialysis does not tend to help libido. Testosterone replacement may be the solution.

 

Else started up a discussion around the psychological implications of a ‘swine flu’ pandemic and the gradual unfolding nature of such a situation. She recommended a good read about the medieval plague and wondered whether there would be mass panic, noting that this is not what has happened in Mexico – where people have tended to remove themselves from society. The Leeds response pointed out that encephalitis lethargica overlapped with the Great War flu pandemic and complicated interpretation of the psychological aftermath in that situation.

 

The role of politicians in such a situation was cited – and false reassurance from them tended to incite panic more than realistic reporting of a serious situation. The latter was more likely to bring people together in a useful way.

 

April 2009


Dear JISC followers, our March case of possible psychogenic blindness had a ‘midazolam interview’. This only made the patient drowsy. The subsequent plan was to see a special neurological ophthalmologist and a psychologist hypnotherapist. The impossibility of truly knowing for sure whether this was conversion blindness or cortical blindness was iterated.

 

Clinicians were directed to BMJ WWI reports on ‘hysterical blindness’.

 

Ophthalmic side effects of citalopram were also cited.

 

Experiences of abreaction were shared – including 3 patients who when sedated clinically improved and then reverted back to conversion state when sedation wore off. Advice on how to do abreaction was also given.

 

Alcohol screening in A&E was discussed and Bradford have trained their staff online to use AUDIT C. They will let us know the effectiveness of this.

 

PCTs asking for a service spec for liaison: how do we as existing ‘providers’ make a case for at least what we have, or better! Advice to work with the commissioner, give evidence of effectiveness, build up good relationships with ‘stakeholders’; give information about benchmarking various components of the service; get reviews from the acute trust; offer to help write the spec; GP feedback if positive; and service user feedback. Helpful if there is dedicated management time.

 

TTOs from hospital and ensuring this is safe for our patients especially those who have overdosed: one good idea is to put a prompt in electronic records to consider a limited Px for some patient groups.

 

What to do when an HIV patient stops taking treatment: a case was described (by me actually!) and the response was brilliant – encompassing psychodynamic possible reasoning (feelings of abandonment at end of therapy), ‘anaclitic despair’; what the analyst might say; explore rationality of his thinking with him; use a motivational interviewing style; advice to look at CD4 and viral load and consider if mood problem has an organic component; consideration of cognitive deficit and whether this is in part a capacity issue; consideration of subtle cognitive change e.g. frontal lobe causing poor concordance.

 

Finally, Munchausens in the ED: at what point do we make a confident diagnosis and then how to manage, as CMHTs often are not acceptable to these patients and vice versa.

 

 

March 2009


 

A very full month for our global liaison expertise at its best - in particular a case of possible psychogenic blindness from Sydney and how to tease out whether this is organic - or not. There was the often present mix in the history of head injury amidst psychosocial stress factors and equivocal investigations.


Responses included recommendations to have VEPs, lorazepam 'abreaction' (and how to do this, from Leeds), to delve further into the family and the patient's experience of the war in Lebanon in the 1980s. Similar, though perhaps 'easier' (more clear psychogenicity) cases were cited and the whole discussion makes for great reading. 


Also not to forget (again Leeds) that the odder presentations may be linked in some way to as yet undiagnosed brain disease.

 

Another case of probable severe somatoform pain disorder and Leeds' offer to assess on their specialist Liaison unit. Questions raised of where and how (formal/informal?) to treat this patient and problems with treatment of such cases on a general psychiatric unit. Bristol also have a specialist somatoform disorder service, and suggestion made that these patients should be referred to specialist units to start making cases for more units nationally.

 

Non-oral treatment of depression was a hot topic (case presented), with these useful references:

 


Options recommended were fluoxetine drops under the tongue, orodispersible mirtazepine (but no mucosa), iv cipramil, iv clomipramine, rectal amitriptyline and transdermal selegeline, ECT and high quality psychological input.
Kindly we were also given this as yet unpublished helpful source.

 

Psycho-oncology business cases were discussed with a useful document citing evidence-base (see the archive!).

 

Finally, our colleague from St. Helier is part of a UK Royal College of Psychiatrists Steering Group to compile a report on "Self Harm and Suicide" with a focus on risk and barriers to implementation of good practice. Lord Alderdice is chair – so political weight here potentially.

 

Many thoughtful responses to this which included a desire to see assessment tools discussed (better for predicting low risk), a suggestion to broaden what is risk (e.g. risk of poorly trained assessor assessing!) and think about increased physical morbidity too in this group.

 

Also to think about need; to think about treatment services; a clear description of self harm in North London which I think beautifully captures three types of patient we see and how A&E view them (see archive again!).

 

And finally some excellent presentations from Prague (via Leicester):

 

  1. Workshop on getting published.
  2. Talk on detecting depression in cancer settings.


 

February 2009


 

Two tricky requests were made this month on the site: the first for references on the epidemiology of pseodoseizures (other than Psychodynamics and psychiatric diagnoses of pseudoseizure subject Bowman 1996, Am J Psych), and more generally for figures of 'ordinary' somatisers who go on to become more dramatic conversion disorders.

 

A recommended 'somewhere to start' was Epilepsy and Behaviour Volume 4, 2003 - 'Psychogenic nonepileptic seizures: review and update' by Reuber and Elger.

 

The next was for help with a talk to commissioners (no pressure) about the role of liaison psychiatry in reducing the burden of personality disorders with reference to medically unexplained symptoms and self harm presentations to A&E.

 

We were reminded of applicable NICE guidelines in this field for BPD and DBT for self harm, as well as DoH emphasis on management of MUS in primary care. This discussion evolved into concern raised about equating MUS with PD with mention of the old notion of 'moral insanity' potentially being applied also to MUS - and concern that these patients may be seen to have inherent defects, lack of personal responsibility etc.

 

A suggestion was made to consider the concept of 'enduring distress' as applicable to MUS as preferable to PD.

 

And finally - a part-time psychooncology post has been advertised in the Wirral.

 

 

January 2009


 

A very busy month for the site – do recommend you look at the archive, but in summary there were new consultant posts to be advertised in Cheshire and Poole.

 

An international discussion ensued about the sedation of agitated/aggressive/difficult to control delirious patients which focussed on which drug – Lorazepam? Haloperidol? Midazolam? Quetiapine? Risperidone?

 

There were different experiences of all of these – haloperidol +/- lorazepam seemed the first choice for many though when there was organic brain involvement e.g. in HIV, TB, haemophilia.

 

The side effects (EPS) were problematic with the typical antipsychotics. Atypical neuroleptics +/- lorazepam were usually the choices though experience of neutropenia with quetiapine was an issue with one clinician. In ITU where prolonged sedation required, midazolam is used.

 

Can I recommend the annual UK Psychodermatology conference which took place in January – this was the programme:

 

Finally, this is a conference in Southampton in March for a medical update particularly for old age psychiatrists.

 

 

December 2008


 

Earlier this month there was a discussion about providing a liaison service for survivors of cancer. This was prompted by a request for any experience or models of service for a trust which had commissioned a pilot for group therapy for cancer survivors. In response, research headed by Sharpe and White was recommended reading on the subject including a 2008 Lancet study that showed a nurse therapist was effective. Other cited papers included Rehse and Pukrop (2003) which looked at alleviating stress and life quality. It was acknowledged that providing an economic argument for a service was more difficult. Another contributor mentioned an Australian literature review which ranked the evidence base.

 

Some of us completed a questionnaire on Deprivation of Liberty training which had already been filled out by a London Professor!

 

We were reminded of the Prague conference this March – as if we could forget!

 

Later this month was a discussion about setting targets for a liaison service – particularly whether there was anything new. One response spoke of collecting liaison data, analysis of figures, and e.g. noting that in a month a quarter of liaison referrals were re-referrals – and could that be a target for intervention?

 

 

November 2008


 

Justin Shute posted us to let us know of new post for an old age liaison consultant in the North Middlesex Hospital, Barnet, funded by acute trust (quality and length of stay initiative for over 65s).
‘We are a small friendly team of one hoping to become two. Work will mainly be with older adults as part of the generic liaison service. Apply through the NHS jobs website.

Liaison JISC survey results
Only 12%(24) responded – 13/24 were ‘liaison psychiatrists’, 16/24 were consultant level, 4 SpRs, 3 Liaison nurses (2g and 1e). 2/24 were psychologists, 1/24 professor, 1/24 research officer, 3/24 general adult psychiatrists.


Just over 10% of respondents thought the site was:

 

  • difficult to use
  • generated an unacceptable volume of e-mails
  • the site was used inappropriately.

 

In other words, nearly 90% are happy with how the site is used and think it's usable.

 

 

Dr Christopher Ryan, Director, Consultation-Liaison Psychiatry and Senior Clinical Lecturer, Westmead Hospital and the University of Sydney – has sent us the details of a paper he has written on this case for those interested

 

 

Case of psychosis with hypothyroidism and hydrocephalus – How long to treat psychosis? Dr Butler


 

There was a lively debate on the use of the Australian Triage scale following self harm, as recommended by NICE, particularly in the context of low resources in A&E. The views ranged from stating that most patients would in case be referred to Mental Health following a 2 minute triage, to services who has implemented the Manchester Triage Scale, modified to ensure that all mental health did not appear to need high risk triage.

 

For categorising urgency for calling for mental health assessment some use a modified the Hart/Harrison assessment matrix for mental health problems recommended on the CRU self harm service improvement website. That is a mix between clinical assessment and tick box system for ED staff to allocated mental health problems into risk category, with the risk category (red, orange, yellow, green) determining response.

 

For example green and yellow people get sent home and the crisis team phones them the next day (although many decline further assessment), the red are seen immediately and the orange ones are discussed.

 

This model may not suit all services, however, and in particular the question was raised whether  contacting the green and yellow patients the following day would meet the current NICE guidleines?

 

 

Summaries by Jackie Gordon
Liaison Psychiatry, Worthing


Return to homepage


© 2010 Royal College of Psychiatrists